2011•Journal of Cardiac FailureRequires access

Cystatin C as a Biomarker of Worsening Renal Function in Acute Heart Failure: Insights from the DOSE Study

Raquel Bennett-Gittens, Javed Butler, Steve E. McNulty, Anekwe Onwuanyi, Adefisayo Oduwole, Mike Felker, Adrian F. Hernandez, Kerry L. Lee, Brenda Lankford, Elizabeth Ofili

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Cystatin C, Medicine, Biomarker, Renal function, Internal medicine, Heart failure, Cardiology, Creatinine

Back to paper search Browse research topics Original source

Cystatin C as a Biomarker of Worsening Renal Function in Acute Heart Failure: Insights from the DOSE Study — Research Paper | ScholarLens